VERU-111 analogs
- Generic Name
- VERU-111 analogs
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2021-10-15
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Veru Inc.
- Registration Number
- NCT05079360
- Locations
- 🇺🇸
Ironwood Cancer and Research Centers, Chandler, Arizona, United States
🇺🇸California Research Institute (CRI), Los Angeles, California, United States
🇺🇸Banner Health/ Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .
- Conditions
- Metastatic Triple Negative Breast Cancer
- Interventions
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- Veru Inc.
- Registration Number
- NCT05008510
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent
- Conditions
- Metastatic Castration-resistant Prostate CancerAndrogen Resistant Prostatic Cancer
- Interventions
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- Veru Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT04844749
- Locations
- 🇺🇸
Tower Urology, Los Angeles, California, United States
🇺🇸Associated Urologists of North Carolina, Raleigh, North Carolina, United States
🇺🇸Comprehensive Urologic Care, Lake Barrington, Illinois, United States
VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
- First Posted Date
- 2021-04-13
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Veru Inc.
- Target Recruit Count
- 204
- Registration Number
- NCT04842747
- Locations
- 🇺🇸
Methodist Hospital, Saint Louis Park, Minnesota, United States
🇲🇽Hospital General de Culiacán, Culiacán, Mexico
🇧🇬Multiprofile Hospital for Active Treatment - Dr. Atanas Dafovski AD, Kardzhali, Department of Pneumology and Phthisiatry, Dept. of Pneumology & Phthisiatry, Kardzhali, Bulgaria
COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Veru Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT04388826
- Locations
- 🇺🇸
Methodist Hospital, Saint Louis Park, Minnesota, United States
🇺🇸Regions Hospital, Saint Paul, Minnesota, United States
🇺🇸Memorial Hermann Memorial City Hospital, Houston, Texas, United States
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
- Conditions
- Metastatic Castration Resistant Prostate Cancer
- Interventions
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Veru Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT03752099
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland, United States
🇺🇸Urology of Virginia, Virginia Beach, Virginia, United States
🇺🇸Urology Clinics of North Texas, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.